Published in Exp Cell Res on February 01, 1997
Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest (2000) 5.88
MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med (2008) 1.13
Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg (2011) 1.09
Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proc Natl Acad Sci U S A (2001) 1.02
Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase. Jpn J Ophthalmol (2008) 0.96
VEGF is involved in the increase of dermal microvascular permeability induced by tryptase. ISRN Dermatol (2012) 0.75
Opioids and opioid receptors orchestrate wound repair. Transl Res (2017) 0.75
Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest (2000) 5.88
Circulating activated endothelial cells in sickle cell anemia. N Engl J Med (1997) 5.13
Measuring circulating cell-derived microparticles. J Thromb Haemost (2004) 2.61
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest (2000) 2.47
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp Cell Res (2004) 2.25
Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer (1997) 2.20
Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med (1980) 2.14
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood (2000) 2.10
Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest (1982) 1.93
VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res (1999) 1.91
Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc Res (2000) 1.67
Reperfusion injury pathophysiology in sickle transgenic mice. Blood (2000) 1.65
Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol (2001) 1.61
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol (2000) 1.60
Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients? Clin Oncol (R Coll Radiol) (2010) 1.60
Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res (1994) 1.59
CD36-positive stress reticulocytosis in sickle cell anemia. J Lab Clin Med (1996) 1.59
Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest (1998) 1.58
Intermediate-term results of percutaneous transvenous mitral commissurotomy in children less than 12 years of age. Catheter Cardiovasc Interv (2005) 1.53
The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clin Haematol (1985) 1.51
Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver tissue. Clin Chem (1975) 1.49
Cardiac amyloidosis--an update. Indian Heart J (2004) 1.47
Drug therapy of cardiac diseases in children. Indian Pediatr (2009) 1.46
Double blind, placebo controlled trial on the cytoprotective effect of misoprostol in subjects with rheumatoid arthritis, osteoarthritis and seronegative spondarthropathy on NSAIDs. J Assoc Physicians India (1991) 1.39
alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am J Physiol (1995) 1.38
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res (2000) 1.34
Intracellular targets in heme protein-induced renal injury. Kidney Int (1998) 1.33
Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci U S A (1976) 1.33
Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis (1999) 1.31
Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer (1994) 1.24
Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood (1992) 1.24
Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia. Blood (1984) 1.23
Influence of treatment and response status on infection risk in multiple myeloma. Am J Med (1981) 1.21
Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood (2001) 1.17
Auto-oxidation and a membrane-associated 'Fenton reagent': a possible explanation for development of membrane lesions in sickle erythrocytes. Clin Haematol (1985) 1.16
Eales disease--an update. Surv Ophthalmol (2002) 1.15
Clinical diversity of sickle cell anemia: genetic and cellular modulation of disease severity. Am J Hematol (1983) 1.14
Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest (1985) 1.14
Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. Blood (1991) 1.14
A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res (1994) 1.14
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett (1997) 1.13
Blood cell abnormalities complicating the hypophosphatemia of hyperalimentation: erythrocyte and platelet ATP deficiency associated with hemolytic anemia and bleeding in hyperalimented dogs. J Lab Clin Med (1974) 1.12
Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest (1993) 1.11
Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer. BMC Med (2011) 1.11
Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res Mol Brain Res (1995) 1.10
Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity. J Clin Invest (1978) 1.08
Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer (1993) 1.08
Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration. Eye (Lond) (2006) 1.07
Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels. J Cell Mol Med (2009) 1.07
Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study. Retina (2005) 1.07
Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: potentiation by chloroquine. Science (1984) 1.06
Successful device closure of an acquired Gerbode defect. Catheter Cardiovasc Interv (2006) 1.05
Antifertility effect of Ocimum sanctum L. Indian J Exp Biol (1972) 1.04
Saccharomyces cerevisiae cells secreting an Aspergillus niger beta-galactosidase grow on whey permeate. Biotechnology (N Y) (1992) 1.03
Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol (1996) 1.03
Nucleosomal histone protein protects DNA from iron-mediated damage. Nucleic Acids Res (1992) 1.03
Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Circulation (2006) 1.03
Synergistic effects of oxidation and deformation on erythrocyte monovalent cation leak. Blood (1990) 1.00
Infective endocarditis--an Indian perspective. Indian Heart J (2005) 0.99
Internucleosomal cleavage of DNA as the sole criterion for apoptosis may be artifactual. J Lab Clin Med (1994) 0.99
Telomerase activity in normal human endothelial cells. Anticancer Res (1997) 0.99
NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol Cell Physiol (2001) 0.98
Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol (2001) 0.98
Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. Br J Cancer (2007) 0.98
Excess heme in sickle erythrocyte inside-out membranes: possible role in thiol oxidation. Blood (1988) 0.98
Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Cancer Res (1984) 0.97
Nonheme iron in sickle erythrocyte membranes: association with phospholipids and potential role in lipid peroxidation. Blood (1988) 0.97
Improved microvascular network in vitro by human blood outgrowth endothelial cells relative to vessel-derived endothelial cells. Tissue Eng (2005) 0.97
Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders. Blood (1981) 0.96
Identification and functional assessment of endothelial P1H12. J Lab Clin Med (2001) 0.96
Lipid hydroperoxides permit deformation-dependent leak of monovalent cation from erythrocytes. Blood (1991) 0.95
Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies. Cancer Res (1984) 0.94
Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination. Cancer Res (2007) 0.94
A learning-enabled neuron array IC based upon transistor channel models of biological phenomena. IEEE Trans Biomed Circuits Syst (2013) 0.93
Carboplatin selectively induces the VEGF stress response in endothelial cells: Potentiation of antitumor activity by combination treatment with antibody to VEGF. Int J Cancer (2004) 0.93
Neural dynamics in reconfigurable silicon. IEEE Trans Biomed Circuits Syst (2010) 0.93
The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med (1998) 0.93
Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun (1995) 0.92
Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood. Cancer Res (1985) 0.91
Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors. Cancer Gene Ther (2010) 0.91
Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein. Cancer Res (1985) 0.91
Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions. Blood (1997) 0.91
Inhibition of erythrocyte Ca2+-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochim Biophys Acta (1986) 0.91
Progressive systemic sclerosis in south India. J Assoc Physicians India (1991) 0.91
Small-molecule-induced folding of a synthetic polymer. Angew Chem Int Ed Engl (2005) 0.90
Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery. Breast (2010) 0.90
Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System. Mol Cancer (2011) 0.89
Slime production is essential for the adherence of Staphylococcus epidermidis in implant-related infections. J Hosp Infect (2011) 0.89
Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation. J Immunol (1985) 0.89
Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes. Cancer Res (1992) 0.89
Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate. Int J Cancer (1997) 0.89
Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma. Cancer Res (1982) 0.88